Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH).

Transfusion medicine reviews

González-Vicent M, Sanz J, Fuster JL, Cid J, de Heredia CD, Morillo D, Fernández JM, Pascual A, Badell I, Serrano D, Fox L, de la Serna J, Benito A, Couselo JM, Molina B, Díaz MÁ, Sanz MÁ.
PMID: 29573905
Transfus Med Rev. 2018 Mar 03; doi: 10.1016/j.tmrv.2018.02.005. Epub 2018 Mar 03.

Autoimmune hemolytic anemia (AIHA) is a complication of allogeneic hematopoietic stem cell transplantation (HSCT) associated with poor outcome. However, an optimal therapeutic approach is lacking. Between 2000 and 2015, 4099 allogeneic HSCT were performed in eight pediatric centers of...

Cite
González-Vicent M, Sanz J, Fuster JL, et al. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH). Transfus Med Rev. 2018;doi: 10.1016/j.tmrv.2018.02.005.
González-Vicent, M., Sanz, J., Fuster, J. L., Cid, J., de Heredia, C. D., Morillo, D., Fernández, J. M., Pascual, A., Badell, I., Serrano, D., Fox, L., de la Serna, J., Benito, A., Couselo, J. M., Molina, B., Díaz, M. �. �., & Sanz, M. �. �. (2018). Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH). Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2018.02.005
González-Vicent, Marta, et al. "Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH)." Transfusion medicine reviews vol. (2018). doi: https://doi.org/10.1016/j.tmrv.2018.02.005
González-Vicent M, Sanz J, Fuster JL, Cid J, de Heredia CD, Morillo D, Fernández JM, Pascual A, Badell I, Serrano D, Fox L, de la Serna J, Benito A, Couselo JM, Molina B, Díaz MÁ, Sanz MÁ. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH). Transfus Med Rev. 2018 Mar 03; doi: 10.1016/j.tmrv.2018.02.005. Epub 2018 Mar 03. PMID: 29573905.
Copy Download .nbib Format: NLM
Viscoelastic Testing in Traumatic Brain Injury: Key Research Insights.

Transfusion medicine reviews

Anderson TN, Schreiber MA, Rowell SE.
PMID: 34607730
Transfus Med Rev. 2021 Oct;35(4):108-112. doi: 10.1016/j.tmrv.2021.08.002. Epub 2021 Sep 04.

The role of viscoelastic testing in the evaluation and management of traumatic brain injury (TBI) remains a subject of ongoing exploration. This review highlights four key publications that provide significant insights into this subject. Holcomb et al. provided early...

Cite
Anderson TN, Schreiber MA, Rowell SE. Viscoelastic Testing in Traumatic Brain Injury: Key Research Insights. Transfus Med Rev. 2021;35(4):108-112doi: 10.1016/j.tmrv.2021.08.002.
Anderson, T. N., Schreiber, M. A., & Rowell, S. E. (2021). Viscoelastic Testing in Traumatic Brain Injury: Key Research Insights. Transfusion medicine reviews, 35(4), 108-112. https://doi.org/10.1016/j.tmrv.2021.08.002
Anderson, Taylor N, et al. "Viscoelastic Testing in Traumatic Brain Injury: Key Research Insights." Transfusion medicine reviews vol. 35,4 (2021): 108-112. doi: https://doi.org/10.1016/j.tmrv.2021.08.002
Anderson TN, Schreiber MA, Rowell SE. Viscoelastic Testing in Traumatic Brain Injury: Key Research Insights. Transfus Med Rev. 2021 Oct;35(4):108-112. doi: 10.1016/j.tmrv.2021.08.002. Epub 2021 Sep 04. PMID: 34607730.
Copy Download .nbib Format: NLM
Epidemiology of Massive Transfusion - A Common Intervention in Need of a Definition.

Transfusion medicine reviews

McQuilten ZK, Flint AW, Green L, Sanderson B, Winearls J, Wood EM.
PMID: 34690031
Transfus Med Rev. 2021 Oct;35(4):73-79. doi: 10.1016/j.tmrv.2021.08.006. Epub 2021 Oct 21.

While massive transfusion (MT) recipients account for a small proportion of all transfused patients, they account for approximately 10% of blood products issued. Furthermore, MT events pose organizational and logistical challenges for health care providers, laboratory and transfusion services....

Cite
McQuilten ZK, Flint AW, Green L, et al. Epidemiology of Massive Transfusion - A Common Intervention in Need of a Definition. Transfus Med Rev. 2021;35(4):73-79doi: 10.1016/j.tmrv.2021.08.006.
McQuilten, Z. K., Flint, A. W., Green, L., Sanderson, B., Winearls, J., & Wood, E. M. (2021). Epidemiology of Massive Transfusion - A Common Intervention in Need of a Definition. Transfusion medicine reviews, 35(4), 73-79. https://doi.org/10.1016/j.tmrv.2021.08.006
McQuilten, Zoe K, et al. "Epidemiology of Massive Transfusion - A Common Intervention in Need of a Definition." Transfusion medicine reviews vol. 35,4 (2021): 73-79. doi: https://doi.org/10.1016/j.tmrv.2021.08.006
McQuilten ZK, Flint AW, Green L, Sanderson B, Winearls J, Wood EM. Epidemiology of Massive Transfusion - A Common Intervention in Need of a Definition. Transfus Med Rev. 2021 Oct;35(4):73-79. doi: 10.1016/j.tmrv.2021.08.006. Epub 2021 Oct 21. PMID: 34690031.
Copy Download .nbib Format: NLM
The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis.

Transfusion medicine reviews

Montroy J, Hutton B, Moodley P, Fergusson NA, Cheng W, Tinmouth A, Lavallée LT, Fergusson DA, Breau RH.
PMID: 29567052
Transfus Med Rev. 2018 Feb 19; doi: 10.1016/j.tmrv.2018.02.003. Epub 2018 Feb 19.

Tranexamic acid (TXA) is an effective hemostatic agent used for the reduction of blood loss and transfusion. However, the safety profile of TXA remains in question due to a potential increased risk of venous thromboembolism. By applying TXA topically...

Cite
Montroy J, Hutton B, Moodley P, et al. The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. Transfus Med Rev. 2018;doi: 10.1016/j.tmrv.2018.02.003.
Montroy, J., Hutton, B., Moodley, P., Fergusson, N. A., Cheng, W., Tinmouth, A., Lavallée, L. T., Fergusson, D. A., & Breau, R. H. (2018). The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2018.02.003
Montroy, Joshua, et al. "The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis." Transfusion medicine reviews vol. (2018). doi: https://doi.org/10.1016/j.tmrv.2018.02.003
Montroy J, Hutton B, Moodley P, Fergusson NA, Cheng W, Tinmouth A, Lavallée LT, Fergusson DA, Breau RH. The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. Transfus Med Rev. 2018 Feb 19; doi: 10.1016/j.tmrv.2018.02.003. Epub 2018 Feb 19. PMID: 29567052.
Copy Download .nbib Format: NLM
Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review.

Transfusion medicine reviews

Pavenski K, Stanworth S, Fung M, Wood EM, Pink J, Murphy MF, Hume H, Nahirniak S, Webert KE, Tanael S, Landry D, Shehata N.
PMID: 29921477
Transfus Med Rev. 2018 Jun 01; doi: 10.1016/j.tmrv.2018.05.004. Epub 2018 Jun 01.

Many transfusion guidelines are available, but little appraisal of their quality has been undertaken. The quality of guidelines may potentially influence adoption. Our aim was to determine the quality of evidence-based transfusion guidelines (EBG) for red cells and plasma,...

Cite
Pavenski K, Stanworth S, Fung M, et al. Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review. Transfus Med Rev. 2018;doi: 10.1016/j.tmrv.2018.05.004.
Pavenski, K., Stanworth, S., Fung, M., Wood, E. M., Pink, J., Murphy, M. F., Hume, H., Nahirniak, S., Webert, K. E., Tanael, S., Landry, D., Shehata, N. (2018). Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2018.05.004
Pavenski, Katerina, et al. "Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review." Transfusion medicine reviews vol. (2018). doi: https://doi.org/10.1016/j.tmrv.2018.05.004
Pavenski K, Stanworth S, Fung M, Wood EM, Pink J, Murphy MF, Hume H, Nahirniak S, Webert KE, Tanael S, Landry D, Shehata N. Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review. Transfus Med Rev. 2018 Jun 01; doi: 10.1016/j.tmrv.2018.05.004. Epub 2018 Jun 01. PMID: 29921477.
Copy Download .nbib Format: NLM
Platelet Storage Lesions: What More Do We Know Now?.

Transfusion medicine reviews

Ng MSY, Tung JP, Fraser JF.
PMID: 29751949
Transfus Med Rev. 2018 Apr 17; doi: 10.1016/j.tmrv.2018.04.001. Epub 2018 Apr 17.

Platelet concentrate (PC) transfusions are a lifesaving adjunct to control and prevent bleeding in cancer, hematologic, surgical, and trauma patients. Platelet concentrate availability and safety are limited by the development of platelet storage lesions (PSLs) and risk of bacterial...

Cite
Ng MSY, Tung JP, Fraser JF. Platelet Storage Lesions: What More Do We Know Now?. Transfus Med Rev. 2018;doi: 10.1016/j.tmrv.2018.04.001.
Ng, M. S. Y., Tung, J. P., & Fraser, J. F. (2018). Platelet Storage Lesions: What More Do We Know Now?. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2018.04.001
Ng, Monica Suet Ying, et al. "Platelet Storage Lesions: What More Do We Know Now?." Transfusion medicine reviews vol. (2018). doi: https://doi.org/10.1016/j.tmrv.2018.04.001
Ng MSY, Tung JP, Fraser JF. Platelet Storage Lesions: What More Do We Know Now?. Transfus Med Rev. 2018 Apr 17; doi: 10.1016/j.tmrv.2018.04.001. Epub 2018 Apr 17. PMID: 29751949.
Copy Download .nbib Format: NLM
Pathophysiology of Trauma-Induced Coagulopathy.

Transfusion medicine reviews

Duque P, Calvo A, Lockie C, Schöchl H.
PMID: 34610877
Transfus Med Rev. 2021 Oct;35(4):80-86. doi: 10.1016/j.tmrv.2021.07.004. Epub 2021 Aug 29.

There is no standard definition for trauma-induced coagulopathy (TIC). However, it could be defined as an abnormal hemostatic response secondary to trauma. The terms "early TIC" and "late TIC" have been recently suggested. "Early TIC" would refer to the...

Cite
Duque P, Calvo A, Lockie C, et al. Pathophysiology of Trauma-Induced Coagulopathy. Transfus Med Rev. 2021;35(4):80-86doi: 10.1016/j.tmrv.2021.07.004.
Duque, P., Calvo, A., Lockie, C., & Schöchl, H. (2021). Pathophysiology of Trauma-Induced Coagulopathy. Transfusion medicine reviews, 35(4), 80-86. https://doi.org/10.1016/j.tmrv.2021.07.004
Duque, Patricia, et al. "Pathophysiology of Trauma-Induced Coagulopathy." Transfusion medicine reviews vol. 35,4 (2021): 80-86. doi: https://doi.org/10.1016/j.tmrv.2021.07.004
Duque P, Calvo A, Lockie C, Schöchl H. Pathophysiology of Trauma-Induced Coagulopathy. Transfus Med Rev. 2021 Oct;35(4):80-86. doi: 10.1016/j.tmrv.2021.07.004. Epub 2021 Aug 29. PMID: 34610877.
Copy Download .nbib Format: NLM
Roles of Four-Factor Prothrombin Complex Concentrate in the Management of Critical Bleeding.

Transfusion medicine reviews

Tanaka KA, Shettar S, Vandyck K, Shea SM, Abuelkasem E.
PMID: 34551881
Transfus Med Rev. 2021 Oct;35(4):96-103. doi: 10.1016/j.tmrv.2021.06.007. Epub 2021 Aug 26.

Four-factor prothrombin complex concentrate (4F-PCC) is the term used to describe a pathogen-reduced, lyophilized concentrate that contains therapeutic amounts of at least 4 coagulation factors: Factor II (FII), Factor VII (FVII), Factor IX (FIX), and Factor X (FX). 4F-PCC...

Cite
Tanaka KA, Shettar S, Vandyck K, et al. Roles of Four-Factor Prothrombin Complex Concentrate in the Management of Critical Bleeding. Transfus Med Rev. 2021;35(4):96-103doi: 10.1016/j.tmrv.2021.06.007.
Tanaka, K. A., Shettar, S., Vandyck, K., Shea, S. M., & Abuelkasem, E. (2021). Roles of Four-Factor Prothrombin Complex Concentrate in the Management of Critical Bleeding. Transfusion medicine reviews, 35(4), 96-103. https://doi.org/10.1016/j.tmrv.2021.06.007
Tanaka, Kenichi A, et al. "Roles of Four-Factor Prothrombin Complex Concentrate in the Management of Critical Bleeding." Transfusion medicine reviews vol. 35,4 (2021): 96-103. doi: https://doi.org/10.1016/j.tmrv.2021.06.007
Tanaka KA, Shettar S, Vandyck K, Shea SM, Abuelkasem E. Roles of Four-Factor Prothrombin Complex Concentrate in the Management of Critical Bleeding. Transfus Med Rev. 2021 Oct;35(4):96-103. doi: 10.1016/j.tmrv.2021.06.007. Epub 2021 Aug 26. PMID: 34551881.
Copy Download .nbib Format: NLM
Efficacy and Safety of Intravenous Iron Therapy for Treating Anaemia in Critically ill Adults: A Rapid Systematic Review With Meta-Analysis.

Transfusion medicine reviews

Geneen LJ, Kimber C, Doree C, Stanworth S, Shah A.
PMID: 35031197
Transfus Med Rev. 2021 Dec 24; doi: 10.1016/j.tmrv.2021.12.002. Epub 2021 Dec 24.

Our objective was to systematically evaluate the efficacy and safety of intravenous (IV) iron therapy for treating anaemia in critically ill adults (>16 years) admitted to intensive care or high dependency units. We excluded quasi-RCTs and other not truly...

Cite
Geneen LJ, Kimber C, Doree C, et al. Efficacy and Safety of Intravenous Iron Therapy for Treating Anaemia in Critically ill Adults: A Rapid Systematic Review With Meta-Analysis. Transfus Med Rev. 2021;doi: 10.1016/j.tmrv.2021.12.002.
Geneen, L. J., Kimber, C., Doree, C., Stanworth, S., & Shah, A. (2021). Efficacy and Safety of Intravenous Iron Therapy for Treating Anaemia in Critically ill Adults: A Rapid Systematic Review With Meta-Analysis. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2021.12.002
Geneen, Louise J, et al. "Efficacy and Safety of Intravenous Iron Therapy for Treating Anaemia in Critically ill Adults: A Rapid Systematic Review With Meta-Analysis." Transfusion medicine reviews vol. (2021). doi: https://doi.org/10.1016/j.tmrv.2021.12.002
Geneen LJ, Kimber C, Doree C, Stanworth S, Shah A. Efficacy and Safety of Intravenous Iron Therapy for Treating Anaemia in Critically ill Adults: A Rapid Systematic Review With Meta-Analysis. Transfus Med Rev. 2021 Dec 24; doi: 10.1016/j.tmrv.2021.12.002. Epub 2021 Dec 24. PMID: 35031197.
Copy Download .nbib Format: NLM
Convalescent Plasma for Patients Hospitalized With Coronavirus Disease 2019: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.

Transfusion medicine reviews

Ling RR, Sim JJL, Tan FL, Tai BC, Syn N, Mucheli SS, Fan BE, Mitra S, Ramanathan K.
PMID: 34782209
Transfus Med Rev. 2021 Oct 10; doi: 10.1016/j.tmrv.2021.09.001. Epub 2021 Oct 10.

Current evidence from randomized controlled trials (RCTs) and systematic reviews on the utility of convalescent plasma (CP) in patients with coronavirus disease 2019 (COVID-19) suggests a lack of benefit. We conducted an updated meta-analysis of RCTs with trial sequential...

Cite
Ling RR, Sim JJL, Tan FL, et al. Convalescent Plasma for Patients Hospitalized With Coronavirus Disease 2019: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Transfus Med Rev. 2021;doi: 10.1016/j.tmrv.2021.09.001.
Ling, R. R., Sim, J. J. L., Tan, F. L., Tai, B. C., Syn, N., Mucheli, S. S., Fan, B. E., Mitra, S., & Ramanathan, K. (2021). Convalescent Plasma for Patients Hospitalized With Coronavirus Disease 2019: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2021.09.001
Ling, Ryan Ruiyang, et al. "Convalescent Plasma for Patients Hospitalized With Coronavirus Disease 2019: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials." Transfusion medicine reviews vol. (2021). doi: https://doi.org/10.1016/j.tmrv.2021.09.001
Ling RR, Sim JJL, Tan FL, Tai BC, Syn N, Mucheli SS, Fan BE, Mitra S, Ramanathan K. Convalescent Plasma for Patients Hospitalized With Coronavirus Disease 2019: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Transfus Med Rev. 2021 Oct 10; doi: 10.1016/j.tmrv.2021.09.001. Epub 2021 Oct 10. PMID: 34782209; PMCID: PMC8502250.
Copy Download .nbib Format: NLM
The Difference in Potential Harms between Whole Blood and Component Blood Transfusion in major Bleeding: A Rapid Systematic Review and Meta-Analysis of RCTs.

Transfusion medicine reviews

Geneen LJ, Brunskill SJ, Doree C, Estcourt LJ, Green L.
PMID: 34844826
Transfus Med Rev. 2021 Nov 03; doi: 10.1016/j.tmrv.2021.10.003. Epub 2021 Nov 03.

Our aim was to assess whether there is a difference in outcomes of potential "all-cause" harm in the transfusion of whole blood (WB) compared to blood components (BC) for any bleeding patient regardless of age or clinical condition. We...

Cite
Geneen LJ, Brunskill SJ, Doree C, et al. The Difference in Potential Harms between Whole Blood and Component Blood Transfusion in major Bleeding: A Rapid Systematic Review and Meta-Analysis of RCTs. Transfus Med Rev. 2021;doi: 10.1016/j.tmrv.2021.10.003.
Geneen, L. J., Brunskill, S. J., Doree, C., Estcourt, L. J., & Green, L. (2021). The Difference in Potential Harms between Whole Blood and Component Blood Transfusion in major Bleeding: A Rapid Systematic Review and Meta-Analysis of RCTs. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2021.10.003
Geneen, Louise J, et al. "The Difference in Potential Harms between Whole Blood and Component Blood Transfusion in major Bleeding: A Rapid Systematic Review and Meta-Analysis of RCTs." Transfusion medicine reviews vol. (2021). doi: https://doi.org/10.1016/j.tmrv.2021.10.003
Geneen LJ, Brunskill SJ, Doree C, Estcourt LJ, Green L. The Difference in Potential Harms between Whole Blood and Component Blood Transfusion in major Bleeding: A Rapid Systematic Review and Meta-Analysis of RCTs. Transfus Med Rev. 2021 Nov 03; doi: 10.1016/j.tmrv.2021.10.003. Epub 2021 Nov 03. PMID: 34844826.
Copy Download .nbib Format: NLM
Blood Donation and Monetary Incentives: A Meta-Analysis of Cost-Effectiveness.

Transfusion medicine reviews

Bruers S.
PMID: 34742615
Transfus Med Rev. 2021 Oct 09; doi: 10.1016/j.tmrv.2021.08.007. Epub 2021 Oct 09.

The effectiveness of monetary incentives to increase altruistic behavior is in dispute. Paying blood donors might be ineffective, as it could decrease altruistic motivations of voluntary donors (motivational crowding-out) or decrease blood quality (increase transmittable infectious disease risks). In...

Cite
Bruers S. Blood Donation and Monetary Incentives: A Meta-Analysis of Cost-Effectiveness. Transfus Med Rev. 2021;doi: 10.1016/j.tmrv.2021.08.007.
Bruers, S. (2021). Blood Donation and Monetary Incentives: A Meta-Analysis of Cost-Effectiveness. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2021.08.007
Bruers, Stijn. "Blood Donation and Monetary Incentives: A Meta-Analysis of Cost-Effectiveness." Transfusion medicine reviews vol. (2021). doi: https://doi.org/10.1016/j.tmrv.2021.08.007
Bruers S. Blood Donation and Monetary Incentives: A Meta-Analysis of Cost-Effectiveness. Transfus Med Rev. 2021 Oct 09; doi: 10.1016/j.tmrv.2021.08.007. Epub 2021 Oct 09. PMID: 34742615.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries